American Society of Clinical Oncology (ASCO) convened an expert panel to review and update evidence-based strategies for breast cancer followup and management in asymptomatic patients following primary, curative therapy. The panel observed the 1996 outcomes criteria that justify the use of a drug or technology in the guideline development process. Therapy was recommended when compelling positive effects to survival, quality of life, and/or cost-effectiveness was demonstrated.
This tool includes a slide set summarizing the expert panel's recommendations as well as a flow sheet health care providers can use to track and manage a patient's breast cancer treatment.
American Society of Clinical Oncology
Disease/Condition-Related; Guideline-Related
Last updated: April 11, 2008.
AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal
Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364